Oncotect The world's first non-invasive at-home cancer screening test for dogs. It is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine. The company’s patent-pending in-vitro scientific test relies on its proprietary technology to detect cancerous metabolites. Oncotect is the only urine-based non-invasive, convenient, affordable, and accessible multi-cancer screening test available for dogs.
A highly accurate, non-invasive, early cancer screening tool, backed by scientific clinical research.
*Clinically tested for over 500 dogs
*50+ Vets used and recommended
*83% Sensitivity, 96% Specificity
*83% Sensitivity, 96% Specificity
*Requires no vet vist
Standard Shipping 3-5 business days
FAQ ABOUT THE PRODUCT
We've got you covered. Below are answers to some of the most frequently asked questions, providing you with all the details you need about this product and its benefits for your pet.